During the past decade, Heart Care Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Heart Care Research" #1 sponsor was "AtheroGenics" with 1 trials, followed by "Brigham and Women's Hospital" with 1 trials sponsored, "Canadian Atherosclerosis Imaging Network" with 1 trials sponsored, "Montreal Heart Institute" with 1 trials sponsored and "Tasly Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heart Care Research" #1 collaborator was "Boston VA Research Institute, Inc." with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator and "University of Minnesota" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Heart Care Research" are "Atherosclerosis" (2 trials), "Myocardial Infarction" (2 trials), "Angina Pectoris" (1 trials), "Coronary Artery Disease" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Heart Care Research" in a lesser frequency.

Most popular intervention types in "Heart Care Research" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "AGI-1067" (1 trials), "High Dose Trivalent Influenza Vaccine" (1 trials), "Placebo" (1 trials), "Sanqi+Bingpian" (1 trials) and "Standard Dose Quadrivalent Influenza Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart Care Research" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Heart Care Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Heart Care Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Heart Care Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".